Do omega-3 fatty acids reduce disease risk, disease activity, and inflammatory biomarkers in patients with SLE and RA?
Omega-3 fatty acids may reduce disease risk and activity in systemic lupus erythematosus and rheumatoid arthritis.
The current study presented solid evidence highlighting the advantageous impact of omega-3 fatty acids on SLE and RA. This was achieved through the reduction of disease risk, the decrease of disease activity, and the mitigation of inflammatory biomarkers. To stratify another autoimmune illness, it is necessary to carry out rigorous evaluations to surpass the existing findings and enhance understanding in this domain.
Hong et al. (Mon,) studied this question.